G3O Stock Overview
Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
S.M.A.I.O S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.40 |
| 52 Week High | €3.42 |
| 52 Week Low | €1.85 |
| Beta | 0.45 |
| 1 Month Change | 12.21% |
| 3 Month Change | 4.29% |
| 1 Year Change | 17.24% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -13.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| G3O | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.9% | 0.7% | -0.5% |
| 1Y | 17.2% | -3.4% | 4.3% |
Return vs Industry: G3O exceeded the German Medical Equipment industry which returned -3.4% over the past year.
Return vs Market: G3O exceeded the German Market which returned 4.3% over the past year.
Price Volatility
| G3O volatility | |
|---|---|
| G3O Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: G3O has not had significant price volatility in the past 3 months.
Volatility Over Time: G3O's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 38 | Philippe Roussouly | smaio.com |
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. The company was incorporated in 2009 and is based in Saint-Priest, France.
S.M.A.I.O S.A. Fundamentals Summary
| G3O fundamental statistics | |
|---|---|
| Market cap | €17.99m |
| Earnings (TTM) | -€902.77k |
| Revenue (TTM) | €6.91m |
2.6x
P/S Ratio-19.9x
P/E RatioIs G3O overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| G3O income statement (TTM) | |
|---|---|
| Revenue | €6.91m |
| Cost of Revenue | €3.05m |
| Gross Profit | €3.86m |
| Other Expenses | €4.76m |
| Earnings | -€902.77k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Oct 15, 2024
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 55.85% |
| Net Profit Margin | -13.06% |
| Debt/Equity Ratio | 14.7% |
How did G3O perform over the long term?
See historical performance and comparison